首页> 外国专利> Derivatives of imidazo 4,5-c - pyridin - 4 - ona, a process for their preparation, their use for preparing a Drug, The Drug base of these compounds.Pharmaceutical compositions containing these compounds and a process for preparing these compositions F

Derivatives of imidazo 4,5-c - pyridin - 4 - ona, a process for their preparation, their use for preparing a Drug, The Drug base of these compounds.Pharmaceutical compositions containing these compounds and a process for preparing these compositions F

机译:咪唑并[4,5-c]-吡啶-4-酮的衍生物,其制备方法,其在药物中的用途,这些化合物的药物基础。含有这些化合物的药物组合物和这些组合物的制备方法F

摘要

1. A new formulation of pyridan [4,5-c] - pyridine-4-ona (1) derivatives;wherein: R represents H, straight or branched chain C 1-6 alkyl or C 3-6 cycloalkyl; R1 represents Ar; R2 represents Ar; R3 represents H, R, R4, Hal, CN, COOH, COOA or CONH2; Ar and Ar independently represent phenyl, unsubstituted or mono, di or trisubstituted naphthyl obiphenyl with R, OH, Hal, CN, NO2, CF3, NH2, NHR, NR2, pyrrolidin-1-yl, piperidin-1-yl, benzyloxy, SO2NH2 , SO2NHR, SO2NR2, -CONHR, -CONR2, - (CH2) n-NH2, - (CH2) n-NHR, - (CH2) nNR2, -O- (CH2) n-NH2, -O- (CH2) n -NHR, -O- (CH2) n-NR2, R4 or jointly substituted with -O- (CH2) mO-; R4 represents -C (= NH) -NH2, -NH-C (= NH) -NH2 or -C (= O) -N = C (NH2) 2 unsubstituted or monosubstituted with -COR, -COOR,-OH o con un grupo protector de aminoconvencional formula (2) o (3)A C1-4 tar; Hal for F, Cl, Br or I; m for 1 or 2; n for 0, 1, 2 or 3; P for 0 or 1. 1. The procedure for the preparation of pyridine [4,5-c] - pyridine-4-ona (1) derivatives;Wherein: (a) they are released from a functional derivative by treatment with a Soviet or hydrogenolysis agent; or (b) a formula compound (1) converts one or more residual R, R1, R2 and / or R3 into one or more different R, R1, R2 and / or R3 residues; and / or converts one or more formula acids into their salts. 1. Preparation of drugs for disease prevention / treatment using chemically acceptable formula compounds (1) and / or SARS salts.
机译:1.一种新的吡啶并[4,5-c]-吡啶-4-ona(1)衍生物的制剂;其中:R代表H,直链或支链C 1-6烷基或C 3-6环烷基; R1代表Ar; R2代表Ar; R3代表H,R,R4,Hal,CN,COOH,COOA或CONH2; Ar和Ar独立地代表未取代的苯基,R1,OH,Hal,CN,NO2,CF3,NH2,NHR,NR2,吡咯烷基-1-基,哌啶-1-基,苄氧基,SO2NH2 ,SO2NHR,SO2NR2,-CONHR,-CONR2,-(CH2)n-NH2,-(CH2)n-NHR,-(CH2)nNR2,-O-(CH2)n-NH2,-O-(CH2)n -NHR,-O-(CH 2)n-NR 2,R 4或被-O-(CH 2)mO-共同取代; R 4代表-C(= NH)-NH2,-NH-C(= NH)-NH2或-C(= O)-N = C(NH2)2未取代或被-COR,-COOR,-OH取代(2)o(3)A C1-4焦油的氨基保护基。 F,Cl,Br或I为Hal; m为1或2; n代表0、1、2或3; P为0或1。1.制备吡啶[4,5-c]-吡啶-4-ona(1)衍生物的方法;其中:(a)通过苏联处理从功能衍生物中释放出来或氢解剂; (b)式(1)的化合物将一个或多个R,R1,R2和/或R3残基转化为一个或多个不同的R,R1,R2和/或R3残基;或和/或将一种或多种通式酸转化为其盐。 1.使用化学上可接受的通式化合物(1)和/或SARS盐制备用于疾病预防/治疗的药物。

著录项

  • 公开/公告号AR020688A1

    专利类型

  • 公开/公告日2002-05-22

    原文格式PDF

  • 申请/专利号AR1999P104991

  • 发明设计人

    申请日1999-10-01

  • 分类号C07D471/04;A61K31/437;A61P7/02;A61P9/10;C07D471/04;C07D221/00;C07D235/00;

  • 国家 AR

  • 入库时间 2022-08-22 00:46:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号